dihydroxyphenylalanine has been researched along with Retroperitoneal Neoplasms in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dy, V | 1 |
Watson, RC | 1 |
Exelby, PR | 1 |
Hajdu, SI | 1 |
Helson, L | 1 |
Kharchenko, AD | 1 |
Kniazev, IuA | 1 |
Bukhny, AE | 1 |
Kovalev, GP | 1 |
Kosiakov, GA | 1 |
2 other studies available for dihydroxyphenylalanine and Retroperitoneal Neoplasms
Article | Year |
---|---|
Improved management of stage III neuroblastoma.
Topics: Age Factors; Antineoplastic Agents; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Human | 1979 |
[Diurnal urine excretion of catecholamines and DOPA in tumors of the sympathetic nervous system in children].
Topics: Adolescent; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Lymphom | 1969 |